Finance

Lists
Q3 2026 earnings • released • EPS beat +26.81% • Revenue beat +60.98%
See results
ABCL:NASDAQ
AbCellera Biologics Inc
$12.50
+5.22%
(+0.62) 1D
$12.94
+3.52% (+0.44)
After hours
Closed: Nov 9, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ABCL...
Open
$11.90
High
$12.74
Low
$11.68
Mkt. cap
4.05B
Avg. vol.
4.53M
Volume
3.00M
52-wk high
$15.02
52-wk low
$2.74
EPS
-$0.54
Beta
1.59
Shares outstanding
324.05M
No. of employees
562
Open
$11.90
High
$12.74
Low
$11.68
Mkt. cap
4.05B
Avg. vol.
4.53M
Volume
3.00M
52-wk high
$15.02
52-wk low
$2.74
EPS
-$0.54
Beta
1.59
Shares outstanding
324.05M
No. of employees
562
News stories
From web sources and news partners
Profile
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
About AbCellera Biologics Inc
CEOCarl Hansen
Employees562
Founded2012
HeadquartersVancouver, British Columbia, Canada
SectorHealth Care
Industry-
Websiteabcellera.com
Analyst ratings
Based on 7 analysts giving stock ratings to ABCL in the past 3 months
Strong buy
Buy
6
Hold
1
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for ABCL in the last 3 months.
Highest
Current $12.50
$30.00 (+140.00%)
Average
$19.86 (+58.88%)
Lowest
$13.00 (+4.00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Roger Song
Jefferies
Buy
Initiated
$21.00
+68%
10/30/2026
Unknown Analyst
UBS
Buy
Initiated
$18.00
+44%
10/11/2026
Alice Nettleton
UBS
Buy
Initiated
$18.00
+44%
10/12/2026
Brian Cheng
J.P. Morgan
Buy
Initiated
$17.00
+36%
09/29/2026
Debanjana Chatterjee
JonesTrading
Buy
Reiterated
$25.00
+100%
09/27/2026
Andrea Newkirk
Goldman Sachs
Hold
Initiated
$13.00
+4%
09/24/2026
Srikripa Devarakonda
Truist Financial
Buy
Reiterated
$30.00
+140%
09/02/2026
Evan Seigerman
BMO Capital
Buy
Maintained
$15.00
+20%
08/17/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
$12.00
-4%
08/07/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Reiterated
$12.00
-4%
08/05/2026
Stephen Willey
Stifel Nicolaus
Buy
Maintained
$9.00
-28%
08/06/2026
Brendan Smith
TD Cowen
Buy
Maintained
-
-
08/05/2026
Last report
Nov 9, 2026
Fiscal period
Q3 2026
-$0.13 / -$0.18
+26.81%beat
Revenue / Est. (USD)
10.64M / 6.61M
+60.98%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
8.96M
44.85M
8.32M
4.05M
Cost of goods sold
55.03M
50.09M
46.66M
45.99M
Cost of revenue
55.03M
50.09M
46.66M
45.99M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24.96M
17.22M
12.33M
13.85M
Operating expense
30.20M
23.34M
19.17M
20.84M
Total operating expenses
85.23M
73.44M
65.83M
66.83M
Operating income
-76.28M
-28.58M
-57.52M
-62.78M
Other non operating income
745.00K
2.16M
4.34M
3.85M
EBT including unusual items
-68.77M
-19.50M
-49.54M
-58.96M
EBT excluding unusual items
-68.77M
-20.50M
-49.54M
-58.96M
Income tax expense
-11.65M
-10.55M
-6.37M
-3.54M
Effective tax rate
16.94%
54.13%
12.86%
6.00%
Other operating expenses
-
-
-
-
Net income
-57.12M
-8.94M
-43.16M
-55.43M
Net profit margin
-637.84%
-19.94%
-519.12%
-1,368.57%
Earnings per share
-0.19
-0.03
-0.14
-0.18
Interest and investment income
6.76M
5.92M
3.64M
-
Interest expense
-
-
-
-42.00K
Net interest expenses
6.76M
5.92M
3.64M
-42.00K
Depreciation and amortization charges
5.25M
6.12M
6.84M
6.99M
EBITDA
-71.03M
-22.46M
-50.68M
-55.79M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps